✦ LIBER ✦

Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer

✍ Scribed by Stacy S. Shord; Stephanie R. Faucette; Heidi H. Gillenwater; Scott L. Pescatore; Roy L. Hawke; Mark A. Socinski; Celeste Lindley

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacology of the paclitaxel–cisplatin

✍ J. R. Kroep; E. F. Smit; G. Giaccone; K. Van der Born; J. H. Beijnen; C. J. Van 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 248 KB

Gemcitabine, ifosfamide and paclitaxel i

✍ F. V. Piantedosi; F. Caputo; G. Mazzarella; M. Gilli; A. Pontillo; D. D’Agostino 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 206 KB

Alternating weekly administration of pac

✍ David Aguiar; José Aguiar; Uriel Bohn 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 207 KB

Paclitaxel and gemcitabine combination i

✍ Athanasios Athanasiadis; George Roussos; Thomas Papakostoulis; Daniela-Carmen At 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 197 KB

Gene polymorphisms, pharmacokinetics, an

✍ M. Joerger; J. A. Burgers; P. Baas; V. D. Doodeman; P. H. M. Smits; R. S. Jansen 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 352 KB

Phase II study of gemcitabine and carbop

✍ Lin Run Wang; Ming Zhu Huang; Guo Bing Zhang; Nong Xu; Xiu Hua Wu 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 385 KB